Lupin on Friday launched Iron Isomaltoside 1000 in India under brand names Isofer and Jilazo.
The drugmaker acquired the exclusive rights to market and sell the injectable formulation from Denmark-based Pharmacosmos A/S.
The drug is currently marketed in 33 countries, including 21 EU nations, under the brand name Monofer. The market for iron injectable drugs in India is valued at ₹310 crore and is currently growing at 17 per cent y-o-y.